These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22625865)

  • 1. Effect of oral contraceptive use on lipid profile in Korean women aged 35-55 years.
    Kim K; Park H
    Contraception; 2012 Nov; 86(5):500-5. PubMed ID: 22625865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood cadmium concentration and lipid profile in Korean adults.
    Kim K
    Environ Res; 2012 Jan; 112():225-9. PubMed ID: 22208951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and measurable cardiovascular risk factors in Korean women aged 20-50 years: the Fourth Korean National Health and Nutrition Examination Survey 2007-2009 (KNHANES IV).
    Lee JY; Ku SY; Kim SH; Hwang SS; Lee HW; Park SM
    Gynecol Endocrinol; 2013 Jul; 29(7):707-11. PubMed ID: 23772783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R; Hilliquin P
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of routine diabetes and lipid screening after age 35 in candidates for or current users of oral contraceptives.
    Kjos SL; Gregory K; Henry OA; Collins C
    Obstet Gynecol; 1993 Dec; 82(6):925-30. PubMed ID: 8233266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
    Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
    Kasule J; Mbizvo M; Makuyana D; Masona D
    Cent Afr J Med; 1991 Dec; 37(12):403-9. PubMed ID: 1806254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral contraceptives on serum lipid profiles of women runners.
    Gray DP; Harding E; Dale E
    Fertil Steril; 1983 Apr; 39(4):510-4. PubMed ID: 6832406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease.
    Hsia SH; Pan D; Berookim P; Lee ML
    Am J Cardiol; 2006 Oct; 98(8):1047-52. PubMed ID: 17027569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of alcohol consumption with lipid profile in hypertensive men.
    Park H; Kim K
    Alcohol Alcohol; 2012; 47(3):282-7. PubMed ID: 22371847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
    Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.